Pfizer Responds To “The Pink Sheet” On Partnerships
Executive Summary
[The following is a copy of a Dec. 6 letter from Pfizer to "The Pink Sheet" objecting to coverage of a speech by CEO Hank McKinnell (1"The Pink Sheet" Dec. 2, p. 14). The article focused on the portion of McKinnell's remarks that covered potential trouble points for partnerships.]
You may also be interested in...
Pfizer To Adopt Pharmacia Marketing PR: Mergers Changing Publicity Skills
Pfizer is preparing to adopt Pharmacia's approach of having a separate marketing PR group as a best practice program for the newly merged companies
Pfizer To Adopt Pharmacia Marketing PR: Mergers Changing Publicity Skills
Pfizer is preparing to adopt Pharmacia's approach of having a separate marketing PR group as a best practice program for the newly merged companies
Pfizer Expects Pliant Partners: Deferring To Pfizer Skills And Strengths
Pfizer expects its partners to defer to Pfizer in areas where it has a clear advantage in established skills and size, rather than push the joint arrangements as a way for the smaller firm to develop new functions